Author

Azat Baglanovich Karabekov

Observed names: A. KARABEKOV, A. Karabekov, Azat Karabekov

ORCID: 0000-0001-9281-4041

Observed ORCID: 0000-0001-9281-4041

OpenAlex ID: A5030364792

Hematopoietic stem cell transplantation for multiple myeloma in Kazakhstan: Ten-year single-center experience

2026 · Vadim Kemaykin, Zhandos Burkitbayev, et al. · Journal of International Medical Research · 2

Case study: Acute plasmoblastic leukemia presentation following effective haploidentical hematopoietic stem cell transplantation therapy

2025 · Azat Karabekov, Madina Abdirgalieva, et al. · Journal of International Medical Research · 2

Critical complications of CAR T-cell therapy: an interdisciplinary approach to early diagnosis and critical care

2026 · Ivan Mishutin, Vadim Kemaykin, et al. · Astana Medical Journal

Use of Azacitidine and Venetoclax (aza+ven) in High-risk Myelodysplastic Syndrome and Acute Myeloid Leukemia Following Myelodysplastic Syndrome: Ex-perience of the National Research Oncology Center

2026 · A. Umargaliyeva, V. Kemaykin, et al. · Eurasian Journal of Oncology and Radiology

PDF

POEMS Syndrome as a Mask of Multiple Myeloma: A Case Report with a Significant Response to Daratumumab Therapy

2026 · Alvina Madieva, Azat Baglanovich Karabekov, et al. · Oncology Nuclear Medicine and Transplantology

PDF

The Role of CD56 as an Immunophenotypic Marker in the Clinical Course of Multiple Myeloma

2026 · Azat Karabekov, Vadim Kemaikin, et al. · Journal of Clinical Medicine

PDF

Case Report: Autologous stem cell transplantation in a patient diagnosed with AL amyloidosis in Kazakhstan

2026 · Olga Kolesnikova, Vadim Kemaykin, et al. · Frontiers in Oncology

PDF

Treatment of Burkitt lymphoma in real-world setting: findings on 104 consecutive cases diagnosed and treated in Kazakhstan over the last decade

2026 · Akmaral Jazyltayeva, Nazarii Shokun, et al. · Annals of Hematology

PDF

Impact of CD56 Expression on Plasma Cells in Patients with Newly Diagnosed Multiple Myeloma

2026 · Azat Karabekov, Vadim Kemaykin, et al. · Astana Medical Journal

PDF

Clinical and Pharmacoeconomic Analysis of First- and Second-line Therapy With Bruton Tyro-sine Kinase Inhibitors for Chroniclymphocytic Leukemia in Kazakhstan

2025 · L. Turgunova, A. Klodzinskiy, et al. · Oncologia i radiologia Kazakhstana

PDF

Diagnosis and Treatment of HHV-8–Associated Multicentric Castleman Disease: a Clinical Case From the National Scientific Oncology Center

2025 · Aidana Meirkhanovna Shalkarbekova, Azat Baglanovich Karabekov, et al. · Oncology Nuclear Medicine and Transplantology

PDF

Hodgkin’s Lymphoma as a Rare Variant of Richter's Syndrome in Chronic Lymphocytic Leukemia: A Clinical Case Description

2025 · Gulnur Mamyr, Azat Karabekov, et al. · Oncology Nuclear Medicine and Transplantology

PDF

The Results of Complex Therapy of Hemoblastoses With Covid-19: Single-center Experience at the Cvi-1 Department of the National Research Oncology Center (astana, Kazakhstan)

2024 · R. VILDANOVA, A. MUKAZHANOV, et al. · Oncologia i radiologia Kazakhstana

PDF

Successful Mobilization of Peripheral Hematopoietic Stem Cells in a Patient with Multiple Myeloma

2023 · Azat Karabekov · Oncology kz

PDF

Case series of complex therapy of hemoblastosis in the context of COVID-19.

2022 · Vadim Kemaykin, Ruzal Vildanova, et al.

PDF

Case series of complex therapy of hemoblastosis in the context of COVID-19

2021 · Jamilya Saparbay, Vadim Kemaykin, et al. · Journal of Clinical Medicine of Kazakhstan

PDF

Works count: 16

Citation count: 4

H-index: 2

I10-index: